Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2026-01-20 @ 3:07 PM
Study NCT ID:
NCT04093466
Status:
RECRUITING
Last Update Posted:
2024-10-17
First Post:
2019-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
Sponsor:
Beijing Konruns Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumor | View |
Keywords: